Association of ST2 levels with cardiac structure and function and mortality in outpatients

American Heart Journal

Volumn 160, Issue 4, 2010, Pages 721-728

  Daniels, Lori B ^a   Clopton, Paul ^a,b   Iqbal, Navaid ^b   Tran, Kimberly ^b   Maisel, Alan S ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; DIURETIC AGENT; INTERLEUKIN 1 RECEPTOR; ST2 PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN;

AGED; ARTICLE; CARDIOVASCULAR RISK; CREATININE CLEARANCE; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART SIZE; HUMAN; HYPOKINESIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; BLOOD; CAUSE OF DEATH; COMPARATIVE STUDY; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FOLLOW UP; HEART ATRIUM; HEART CONTRACTION; HEART DISEASE; HEART MUSCLE; HEART VENTRICLE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL RATE; TRENDS; UNITED STATES;

AGED; CALIFORNIA; CAUSE OF DEATH; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART DISEASES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; OUTPATIENTS; PROGNOSIS; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN-1; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77957848557     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.06.033     Document Type: Article

References (32)

1. Yanagisawa K., Tsukamoto T., and Takagi T. Murine ST2 gene is a member of the primary response gene family induced by growth factors FEBS Lett 302 1992 51 53
2. Kieser A., Goodnight J., and Kolch W. Identification of the primary growth response gene, ST2/T1, as a gene whose expression is differentially regulated by different protein kinase C isozymes FEBS Lett 372 1995 189 193
3. Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor FEBS Lett 258 1989 301 304
4. Townsend M.J., Fallon P.G., and Matthews D.J. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses J Exp Med 191 2000 1069 1076
5. Schmitz J., Owyang A., and Oldham E. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
6. Sanada S., Hakuno D., and Higgins L.J. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system J Clin Invest 117 2007 1538 1549
7. Weir R.A., Miller A.M., and Murphy G.E. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction J Am Coll Cardiol 55 2010 243 250
8. Weinberg E.O., Shimpo M., and Hurwitz S. Identification of serum soluble ST2 receptor as a novel heart failure biomarker Circulation 107 2003 721 726
9. Januzzi J.L. Jr., Peacock W.F., and Maisel A.S. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study J Am Coll Cardiol 50 2007 607 613
10. Rehman S.U., Mueller T., and Januzzi J.L. Jr Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure J Am Coll Cardiol 52 2008 1458 1465
11. Sabatine M.S., Morrow D.A., and Higgins L.J. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction Circulation 117 2008 1936 1944
12. Shimpo M., Morrow D.A., and Weinberg E.O. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction Circulation 109 2004 2186 2190
13. Weinberg E.O., Shimpo M., and De Keulenaer G.W. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction Circulation 106 2002 2961 2966
14. Shah R.V., Chen-Tournoux A.A., and Picard M.H. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea Circ Heart Fail 2 2009 311 319
15. Lang R.M., Bierig M., and Devereux R.B. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
16. Feigenbaum H. Echocardiography 1999 Lea and Febiger Philadelphia (PA)
17. Schiller N.B., Shah P.M., and Crawford M. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
18. Dieplinger B., Januzzi J.L. Jr., and Steinmair M. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma-the Presage ST2 Assay Clin Chim Acta 409 2009 33 40
19. Sheen V., Bhalla V., and Tulua-Tata A. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease Am Heart J 153 2007 244.e241 244.e245
20. Wu A.H., Packer M., and Smith A. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study Clin Chem 50 2004 867 873
21. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
22. Vervoort G., Willems H.L., and Wetzels J.F. Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation Nephrol Dial Transplant 17 2002 1909 1913
23. Pencina M.J., D'Agostino R.B. Sr, and D'Agostino R.B. Jr Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 [discussion 207-112]
24. Martinez-Rumayor A., Camargo C.A., and Green S.M. Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease Am J Clin Pathol 130 2008 578 584
25. Maisel A., Mueller C., and Adams K. Jr. State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 2008 824 839
26. Zethelius B., Berglund L., and Sundstrom J. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2008 2107 2116
27. Kazanegra R., Cheng V., and Garcia A. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study J Card Fail 7 2001 21 29 (Pubitemid 32285185)
28. Oshikawa K., Kuroiwa K., and Tago K. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation Am J Respir Crit Care Med 164 2001 277 281
29. Oshikawa K., Yanagisawa K., and Tominaga S. ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation Biochem Biophys Res Commun 299 2002 18 24
30. Tajima S., Oshikawa K., and Tominaga S. The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis Chest 124 2003 1206 1214
31. Oshikawa K., Kuroiwa K., and Tokunaga T. Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid Respir Med 95 2001 532 533
32. Delyani J.A., Robinson E.L., and Rudolph A.E. Effect of a selective aldosterone receptor antagonist in myocardial infarction Am J Physiol Heart Circ Physiol 281 2001 H647 H654